Format

Send to

Choose Destination
Int J Nephrol Renovasc Dis. 2015 Aug 18;8:91-9. doi: 10.2147/IJNRD.S88467. eCollection 2015.

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events.

Author information

1
Department of Nephrology and Hypertension, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan ; Department of Anatomy, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
2
Department of Cardiology, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
3
Department of Nephrology and Hypertension, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.

Abstract

PURPOSE:

Contrast medium (CM) induces tubular hypoxia via endothelial damage due to direct cytotoxicity or viscosity. Urinary liver-type fatty acid binding protein (L-FABP) increases along with tubular hypoxia and may be a detector of systemic circulation injury. The aim of this study was to evaluate the clinical usefulness of detecting increases in urinary L-FABP levels due to administration of CM, as a prognostic biomarker for cardiovascular disease in patients without occurrence of CM-induced nephropathy undergoing cardiac catheterization procedure (CCP).

METHODS:

Retrospective longitudinal analyses of the relationship between urinary L-FABP levels and occurrence of cardiovascular events were performed (n=29). Urinary L-FABP was measured by ELISA before CCP, and at 6, 12, 24, and 48 hours after CCP.

RESULTS:

Urinary L-FABP levels were significantly higher at 12 hours (P<0.05) and 24 hours (P<0.005) after CCP compared with before CCP, only in the patients with occurrence of cardiovascular events (n=17), but not in those without cardiovascular events (n=12). The parameter with the largest area under the curve (0.816) for predicting the occurrence of cardiovascular events was the change in urinary L-FABP at 24 hours after CCP. The difference in urinary L-FABP levels (ΔL-FABP ≥11.0 μg/g creatinine) between before CCP and at 24 hours after CCP was a risk factor for the occurrence of cardiovascular events (hazard ratio, 4.93; 95% confidence interval, 1.27-19.13; P=0.021).

CONCLUSION:

Measurement of urinary L-FABP before CCP and at 24 hours after CCP in patients with mild to moderate renal dysfunction may be an important indicator for risk stratification of onset of cardiovascular events.

KEYWORDS:

L-FABP; cardiovascular event; chronic kidney disease; contrast medium; renal dysfunction; urinary biomarker; urinary liver-type fatty acid binding protein

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center